Idogen publishes interim report for 1 January – 31 March 2022
Idogen AB's interim report for January to March 2022 is available on the company's website https://idogen.com/en/investors/financial-reports/ First quarter (January-March 2022) • Other operating income amounted to KSEK 0 (1,679) • Operating loss was KSEK -10,712 (-10,651) • Loss for the quarter totalled KSEK -10,692 (-10,531) • Cash flow from operating activities was KSEK -18,061 (-9,952) • Loss per share before dilution was SEK -0.25 (-0.58). Loss per share after dilution was SEK -0.25 (-0.58) Significant events in the first quarter • Idogen submits an